Get access

Long-term Survival in Giant Cell Arteritis Including Temporal Arteritis and Polymyalgia Rheumatica

A Follow-up Study of 90 Patients Treated with Corticosteroids

Authors

  • RUNE ANDERSSON,

    Corresponding author
    1. Department of Infectious Diseases, Östra Hospital, and the Department of Internal Medicine II, Sahlgrenska Hospital, University of Göteborg, Göteborg, Sweden
      Department of Infectious Diseases, Östra Hospital, S-41685 Göteborg, Sweden.
    Search for more papers by this author
  • BO-ERIC MALMVALL,

    1. Department of Infectious Diseases, Östra Hospital, and the Department of Internal Medicine II, Sahlgrenska Hospital, University of Göteborg, Göteborg, Sweden
    Search for more papers by this author
  • BENGT-ÅKE BENGTSSON

    1. Department of Infectious Diseases, Östra Hospital, and the Department of Internal Medicine II, Sahlgrenska Hospital, University of Göteborg, Göteborg, Sweden
    Search for more papers by this author

Department of Infectious Diseases, Östra Hospital, S-41685 Göteborg, Sweden.

Abstract

ABSTRACT Ninety patients with giant cell arteritis (GCA) were followed for 9–16 years after diagnosis. Corticosteroids were given to all but one patient. Forty-two patients died during the observation period (27 women and 15 men). The survival was compared with that in the general population and found not to be reduced among the GCA patients. In fact, we found a lower mortality than expected after five years from diagnosis (p<0.05). We did not see any increase in deaths due to vascular or malignant diseases in our patients.

Get access to the full text of this article

Ancillary